Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Ftisadtsk acetate | 99.66% | 1029.10 | 10 MG
Supplier: Medchemexpress LLC HYP3146A10MG
FTISADTSK acetate is an endogenous stable signature peptide derived from Trastuzumab. It is monitored by selected reaction monitoring (SRM) and is intended for research use only.
- Endogenous stable signature peptide
- Monitored by selected reaction monitoring (SRM)
- For research use only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?